Results 241 to 250 of about 173,727 (367)

Pulmonary Hemosiderosis Due to Mitral Valvular Heart Disease [PDF]

, 1999
Eung Yeop Kim, Taesung Kim, Jongho Han, Kyung Soo Lee   +3 more
openalex   +1 more source

Real Time Hemodynamic Monitoring During M‐TEER Using Electrical Cardiometry

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Mitral regurgitation is a common valvular dysfunction causing patient morbidity and mortality. Mitral transcatheter edge‐to‐edge repair (M‐TEER) allows grasping of valvular leaflets and approximation via a small implant, thus reducing mitral regurgitation (MR).
Andreas Goldschmied, Manuel Sigle, Ioannis Toskas, Monika Zdanyte, Mareike Bladt, Meinrad Gawaz, Tobias Geisler   +6 more
wiley   +1 more source

Global, Regional, and National Burden of Valvular Heart Disease, 1990 to 2021. [PDF]

J Am Heart Assoc
Chen QF, Shi S, Wang YF, Shi J, Liu C, Xu T, Ni C, Zhou X, Lin W, Peng Y, Zhou XD.   +10 more
europepmc   +1 more source

Safety and Efficacy of a Plug‐Based Vascular Closure Device After Percutaneous Microaxial Flow Pump in the Treatment of Complex and High‐Risk Indicated Patients

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Femoral large‐bore vascular access is an important and constantly increasing technique in interventional treatment. Temporary circulatory support in complex and high‐risk indicated patients (CHIP) presents a challenge in terms of postinterventional access site closure.
Jörg W. Schröder, Norman Mangner, Felix J. Woitek, Kai U. Markus, Michael Lehrke, Felix Vogt, Marlo Verket, Alexandros Siskos, Moritz Biener, Benjamin Meder, Nicolas M. Van Mieghem   +10 more
wiley   +1 more source

Computational modelling of valvular heart disease: haemodynamic insights and clinical implications. [PDF]

Front Bioeng Biotechnol
Šeman M, Stephens AF, Kaye DM, Gregory SD, Stub D.   +4 more
europepmc   +1 more source

Valvular heart diseases. (2). Mitral valve plasty for infective endocarditis. Especially in active stage.

, 1990
Hideo Ohuchi
openalex   +2 more sources

Impact of Elevated Preprocedural Left Ventricular Filling Pressure on Prognosis of Mild Paravalvular Regurgitation Following Transcatheter Aortic Valve Replacement

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Paravalvular regurgitation (PVR) following transcatheter aortic valve replacement (TAVR) is a complication linked to poor outcomes. The prognostic impact of mild PVR, particularly in patients with elevated preprocedural left ventricular (LV) filling pressure, remains uncertain.
Shumpei Kosugi, Isamu Mizote, Daisuke Nakamura, Hiroki Sugae, Yutaka Matsuhiro, Shota Okuno, Ai Kawamura, Kizuku Yamashita, Koichi Maeda, Kazuo Shimamura, Tomoharu Dohi, Yasuharu Takeda, Yasushi Sakata   +12 more
wiley   +1 more source

Clinical value of NT-proBNP, MPO, and NLR combined with echocardiography in prediction of malignant arrhythmia in elderly patients with valvular heart disease. [PDF]

Perioper Med (Lond)
Liu J, Zhou A, Zheng M, Wang L, Zeng P.
europepmc   +1 more source

Valvular heart diseases (7). Result of cardiac operation for valvular heart disease with cardiac cachexia.

, 1990
Tsuguo Sakamoto
openalex   +2 more sources

PCSK‐9 Inhibitors Can Significantly Improve the Coronary Slow Flow Caused by Elevated Lipoprotein (a) in ST‐Elevation Myocardial Infarction Patients With Chronic Kidney Disease

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Coronary slow flow and no reflow significantly predict poor prognosis in acute myocardial infarction (AMI) patients, especially those with chronic kidney disease (CKD). Early identification of factors contributing to these conditions can mitigate ischemic events and improve outcomes.
Hao Xu, Ziqing Wang, Dan Chen, Haojie Zhang, Junhua Ge, Jian Li   +5 more
wiley   +1 more source